Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections for people with certain types of cancer after receiving chemotherapy or some types of…

Overview
Nipent is a prescription medication approved by the U.S.Food and Drug Administration (FDA) to treat hairy cell leukemia in people with active disease. This drug is indicated in individuals with new hairy cell…

Overview
Novantrone is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemia (ANLL) in adults. Novantrone is also known by its drug name, mitoxantrone. The…

Overview
Oncaspar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL). Oncaspar is often used as a part of a chemotherapy regimen. Oncaspar may…

Overview
Onureg is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia who achieved a first complete remission or complete remission with…

Overview
Radiation therapy (also called RT or radiotherapy) is not commonly used to treat leukemia. However, radiation therapy is used in some cases of acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia…

Overview
Revuforj is approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute leukemia in people aged 1 year and older. It is used in two cases: for relapsed or refractory acute leukemia with a…

Overview
Rezlidhia is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) who have a susceptible isocitrate dehydrogenase-1 (IDH1)…

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and several types of non-Hodgkin lymphoma in adults. It is also indicated for…

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and some types of lymphoma. Rituxan Hycela is usually prescribed together with…

Overview
Rydapt is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myelogenous leukemia (AML) that has tested positive for the FLT3 mutation. Rydapt is also approved…

Overview
Scemblix is approved by the U.S. Food and Drug Administration (FDA) to treat adults with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia, or Ph+ CML, in its early stages…

Overview
Splenectomy is the surgical removal of the spleen, a small organ located on the left side of your abdomen, under the rib cage. A healthy spleen filters old or abnormal red blood cells out of the blood and…

Overview
Sprycel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myeloid leukemia (CML) in the chronic phase who have tested positive for the Philadelphia…

Overview
Tasigna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 1 year or older newly diagnosed with chronic myelogenous leukemia (CML) in the chronic…

Overview
Thioguanine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemias. Thioguanine is often combined with other medications in a chemotherapy…

Overview
Tibsovo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in…

Overview
Treanda, also known by its drug name, bendamustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and indolent B-cell…

Overview
Trisenox is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating acute promyelocytic leukemia (APL) unresponsive to other forms of chemotherapy. Trisenox is reserved for…

Overview
Vanflyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive. This drug…

Overview
Venclexta is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Venclexta is also…

Overview
Vincristine sulfate is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of leukemia, including acute lymphoblastic leukemia (ALL). Vincristine sulfate is…

Overview
Vyxeos is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia (AML) that developed after treatment for another type of cancer, known as…

Overview
Xospata is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myelogenous leukemia (AML) that has tested positive for the FLT3 mutation…

Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular B-cell…